The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.
about
Bleeding related to disturbed fibrinolysisCoagulation Factor XIIIA Subunit Missense Mutations Affect Structure and Function at the Various Steps of Factor XIII ActionAlternatives to allogeneic platelet transfusion.Development and validation of a high throughput whole blood thrombolysis plate assay.Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa.Functional factor XIII-A is exposed on the stimulated platelet surfaceEvaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Lytic and mechanical stability of clots composed of fibrin and blood vessel wall componentsAdvances of Coagulation Factor XIIIHypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.Substrates of Factor XIII-A: roles in thrombosis and wound healing.New developments in the area of factor XIII.Fibrin(ogen) and thrombotic disease.Fibrinogen, red blood cells, and factor XIII in venous thrombosis.Basic mechanisms and regulation of fibrinolysis.Biophysical Mechanisms Mediating Fibrin Fiber Lysis.Minimal factor XIII activity level to prevent major spontaneous bleeds.Defective α2 antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiency.Newly-Recognized Roles of Factor XIII in Thrombosis.Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments.Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot.Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin.FXIII: mechanisms of action in the treatment of hemophilia A.Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2 B2 assembly and steal FXIII-A from native FXIII-A2 B2.Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis.An unmet clinical need: The history of thrombus imaging.Inhibition of Fibrinolysis by Coagulation Factor XIII.Is resistance futile? The role of activated thrombin-activatable fibrinolysis inhibitor resistance in bleeding in factor XI deficiency.Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.Thromboelastometry Identified Alteration of Clot Stabilization and Factor XIII Supplementation Need in a Patient with Decompensated Liver Disease Undergoing Liver Biopsy
P2860
Q28070127-BEB2492A-2BA0-494C-BD9C-103344CD1D75Q28114772-4BD70516-C465-48F8-8BDF-F8FE7725B37EQ33435484-51BA3E98-7EFC-4EB0-AEBE-745DA3B063B3Q33725847-385BBE31-0C78-4AC0-A04C-BA31D09CBA21Q34107034-159AD040-D341-4F32-8E5D-2441A766F6C5Q35023065-36F699F2-65A0-4FED-B86A-0370B65631A9Q35153828-71065DF2-DCF9-4636-9FBF-2743AF6C47ABQ35672990-DBB79117-7BC7-4A02-AF02-75E864F1C672Q35690807-0152A69D-E85E-4C93-973A-6E5FF657F2A5Q36745029-8B8B618B-07DD-4DD2-9B2F-627153A2F04DQ37615581-6813E2A7-1265-4480-A69D-B60569960C3AQ37692590-117E438B-DA22-4F73-90DF-1E0E36C6110CQ38000164-0C65BE58-96A2-429E-8E05-5FDE7C01FF27Q38038687-5AE2A1AE-CB72-455F-96AB-3633DF094577Q38052936-43888375-3714-4AA5-B26C-2076A5B6B892Q38070913-EA5F0A82-0D2D-434C-A3B8-E053AE079FA1Q38117741-304845EE-C40C-43C5-B140-95D617E3D4FDQ38543294-5874D42F-5E69-4198-B4CB-1112149C1403Q38543323-FF394ACA-5643-439B-A673-108D42AE3EEAQ38669149-31D7DD8B-7281-47DA-8D21-65E300ADE5B1Q38688608-14461DD1-0009-4932-A0D6-CA4CA90FA525Q38779362-DA8D4468-16AA-4730-833D-147E3C8D5FFAQ38801273-C8CE261B-39C9-45AF-9096-AA17AA6B04E1Q40379238-B181B3BE-63E2-42D1-817C-0217C0D99A01Q41287140-E4EE73FF-5F44-4D7E-B93B-4406905A4C30Q41825512-93B38833-8A44-4A79-99A0-A1A87BBD573EQ43018362-35341171-A92F-406D-ADDE-D3199BF5D40AQ45859215-2431C748-1981-4B3B-8853-6F7D956EBEEEQ45873332-F3617878-3BB3-4610-8F22-A64B787144C6Q45873682-5E3DDEA3-5E60-4D7A-8688-63702D86D8BEQ45906428-AA87FF6F-CC5B-4BC0-A9DF-EE4EFA309D06Q47177380-75B340E8-782E-43A5-B9F5-3B89B6D3BC62Q53730774-80904ADB-A286-4D50-B62D-A16C995FAA18Q53782006-2AA0734F-36B0-4F0B-8117-8BFD1AB1D7EEQ54458544-2A3911DE-7457-43EF-A4F5-E604FA3BD8B2Q58693392-0EC117CD-0C7B-4C9F-BB69-D76983CB4903
P2860
The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The antifibrinolytic function ...... α₂-antiplasmin cross-linking.
@en
The antifibrinolytic function ...... α₂-antiplasmin cross-linking.
@nl
type
label
The antifibrinolytic function ...... α₂-antiplasmin cross-linking.
@en
The antifibrinolytic function ...... α₂-antiplasmin cross-linking.
@nl
prefLabel
The antifibrinolytic function ...... α₂-antiplasmin cross-linking.
@en
The antifibrinolytic function ...... α₂-antiplasmin cross-linking.
@nl
P2860
P1433
P1476
The antifibrinolytic function ...... h α₂-antiplasmin cross-linking
@en
P2093
Nuala A Booth
Steven R Fraser
P2860
P304
P356
10.1182/BLOOD-2011-02-333203
P407
P577
2011-04-06T00:00:00Z